ScholarIQanswers from OpenAlex
Instituto de Salud Pública de Chile
InstitutionResearch output, impact & collaborations
Instituto de Salud Pública de Chile is a institution indexed in ScholarIQ from OpenAlex.
What is known about Instituto de Salud Pública de Chile?
ScholarIQrecord summary
Instituto de Salud Pública de Chile is a research organisation in Santiago, CL. OpenAlex records 2,334 works and 64,527 citations for it. 936 researchers list it as their most recent affiliation.
How many works does Instituto de Salud Pública de Chile have?
ScholarIQindexed works
Instituto de Salud Pública de Chile has 2,334 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Instituto de Salud Pública de Chile have?
ScholarIQcitation count
Instituto de Salud Pública de Chile has 64,527 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Instituto de Salud Pública de Chile?
ScholarIQresearcher count
Instituto de Salud Pública de Chile has 936 researchers in the ScholarIQ index.
What is the average h-index at Instituto de Salud Pública de Chile?
ScholarIQavg h-index
Instituto de Salud Pública de Chile has an average h-index of 53 in OpenAlex.
What is the ROR of Instituto de Salud Pública de Chile?
ScholarIQror
The ROR for Instituto de Salud Pública de Chile is on the source record.
What is the OpenAlex record for Instituto de Salud Pública de Chile?
ScholarIQopenalex
The OpenAlex for Instituto de Salud Pública de Chile is on the source record.
Who are the most-cited researchers behind Instituto de Salud Pública de Chile?
ScholarIQtop researchers by citations
What are the most-cited papers on Instituto de Salud Pública de Chile?
ScholarIQmost cited works
The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
George T. Grossberg, Facundo Manes, Ricardo Allegri, Luis Miguel Gutiérrez‐Robledo, Sergio Gloger, Lei Xie, Xiaohu Jia, Vojislav Pejović, M. L. Miller, James L. Perhach, Stephen M. Graham
Long-term safety and efficacy of teriflunomide
Paul O’Connor, Giancarlo Comi, Mark S. Freedman, Aaron Miller, Ludwig Kappos, Jean‐Pierre Bouchard, Christine Lebrun‐Frénay, Jan Mareš, Myriam Bénamor, Karthinathan Thangavelu, Jinjun Liang, Philippe Truffinet, Victoria Lawson, Jerry S. Wolinsky, For the Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas, Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas, E. Maida, Eduard Auff, Franz Fazekas, Thomas Berger, Virender Bhan, J-P Bouchard, Pierre Duquette, Mark S. Freedman, François Grand’Maison, M. Kremenchutzky, Caitlin Bourque, Ruth Ann Marrie, Maria Melanson, D. Patry, Paul O’Connor, Joël Oger, Mark Stefanelli, François Jacques, Pablo Venegas, Manoel Miranda, Nancy Beatriz Sánchez Barrientos, E Tenhamm, Sergio Gloger, Gernot Rohde, Jan Mareš, Jette Lautrup Frederiksen, Egon Stenager, Sulev Haldre, Katrin Gross‐Paju, Irina Elovaara, M-L Sumelahti, J-P Erälinna, J-P Erälinna, Martti Färkkilâ, Hanna Harno, Mauri Reunanen, T. Jolma, Cyrille B. Confavreux, William Camu, Pierre Clavelou, Laurent Magy, Marc Debouverie, Gilles Edan, Christine Lebrun‐Frénay, T. Moreau, Jean Pelletier, E Roullet, Sonia Alamowitch, M. Clanet, P. Hautecoeur, Philippe Damier, L. Rumbach, Andrew Chan, Sebastian Schimrigk, J. Haas, Eckart Lensch, Hans‐Christoph Diener, Volker Limmroth, D. Anders, M. Berghoff, Patrick Oschmann, Martin Stangel, M. Berghoff, Achim Frese, Reinhard Kiefer, Martin Marziniak, Uwe K. Zettl, E. Stark, K. Jendroska, Gerd Reifschneider, Massimo Amato, Giacomo P. Comi, V. Cosi, Pamela Gallo, Claudio Gasperini, Angelo Ghezzi, María Trojano, Carlo Pozzilli, E. Montanari, Cees Zwanikken, P.J.H. Jongen, E.Th.L. van Munster, Raymond Hupperts, Bert Anten
Treatment of spontaneous panic attacks with chlomipramine
Sergio Gloger, Leon Grunhaus, B Birmacher, T Troudart
The CUIDEME Study: Determinants of Burden in Chilean Primary Caregivers of Patients with Dementia
Andrea Slachevsky, Marilú Budinich, Claudia Miranda‐Castillo, Javier Núñez-Huasaf, Jaime R. Silva, Carlos Muñoz‐Neira, Sergio Gloger, Oscar Jiménez, Bernardo Martorell, Carolina Delgado
Population-attributable risk of adverse childhood experiences for high suicide risk, psychiatric admissions, and recurrent depression, in depressed outpatients
Sergio Gloger, Pablo Martínez, Alex Behn, M. Victoria Chacón, Marianne Cottin, Dante Diez de Medina, Paul A. Vöhringer
How much of the research on Instituto de Salud Pública de Chile is open access?
ScholarIQopen access share
60%OPEN ACCESS